XAVIS Grants 90,000 Stock Options to 6 Employees... Exercise Price at 1,514 KRW, Premium to Current Price, Minimal Short-Term Dilution
XAVIS granted stock options for 90,000 common shares (approx. 0.29% of total outstanding shares) to 6 executives and employees, resolved by the board on May 29, 2026.
The purpose is to provide long-term performance incentives and align employee interests with company goals.
The exercise price is set at 1,514 KRW, approximately 28% above the closing price of 1,180 KRW on May 28, 2026, meaning the options are currently out-of-the-money, posing no immediate dilution to existing shareholders.
The fair value of the options is estimated at 373.47 KRW per share (using the binomial model), totaling approximately 33.61 million KRW, which will be recognized as an expense over the vesting period.
The exercise period runs from May 29, 2028 to May 28, 2031, reflecting a long-term compensation structure.
[AI Comprehensive Analysis]This stock option grant is small in scale and the exercise price is above the current market price, resulting in low short-term dilution risk and a neutral impact. However, if the stock price exceeds the exercise price in the future, the maximum dilution is about 0.29%, and the expense recognition may slightly reduce net income.